| Dr Vinay Patel, MD | |
|
1070 Vinehaven Dr Ne, Concord, NC 28025-2438 | |
| (704) 783-1840 | |
| (704) 783-1850 |
| Full Name | Dr Vinay Patel |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 18 Years |
| Location | 1070 Vinehaven Dr Ne, Concord, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013048016 | NPI | - | NPPES |
| 201054960 | Medicaid | IN | |
| 000000624697 | Other | KY | ANTHEM # WITH COOP HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2013-01530 (North Carolina) | Primary |
| 207RG0100X | Internal Medicine - Gastroenterology | MD-46717 (Iowa) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Atrium Health University City | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Iowa Regional Medical Center Inc | 3870496417 | 189 |
| Carolinas Medical Center | 4789597477 | 735 |
| Cabarrus Gastroenterology Associates Pllc | 9436059649 | 34 |
News Archive
Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 6 days ago
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 6 days ago
| Entity Name | Cabarrus Gastroenterology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780790592 PECOS PAC ID: 9436059649 Enrollment ID: O20040113000342 |
News Archive
Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 6 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20210827000240 |
News Archive
Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vinay Patel, MD 410 Three Greens Drive, Charlotte, NC 28202 Ph: (803) 422-9201 | Dr Vinay Patel, MD 1070 Vinehaven Dr Ne, Concord, NC 28025-2438 Ph: (704) 783-1840 |
News Archive
Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the closing of a $30 million financing.
The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis (OA) progression. The biomarkers, described in BioMed Central's open access journal Arthritis Research and Therapy, will be useful for the design and interpretation of trials of new disease modifying drugs.
In a message marking Monday's World Malaria Day, Luis Gomes Sambo, WHO's regional director for Africa, noted that this year signifies the end of the U.N. decade to roll back malaria and "offers an opportunity for renewed commitment" to fight the disease, the Angola Press reports.
› Verified 6 days ago
Aishwarya Palwai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-1311 | |
Meghan Rebecca Steiner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Park Dr, Ste 110, Concord, NC 28025 Phone: 704-403-1370 | |
Ashley Noisette Green, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Dr, Ste 330, Concord, NC 28025 Phone: 704-403-1308 | |
Stephen Sean Zouzoulas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Park Dr, Ste 210, Concord, NC 28025 Phone: 704-403-6100 | |
Dr. Ernest F Johnson Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 433 Copperfield Blvd Ne, Concord, NC 28025 Phone: 704-786-7770 Fax: 704-971-0035 | |
Thomas Cary Cameron, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1085 Ne Gateway Ct Ne, Ste 330, Concord, NC 28025 Phone: 704-403-8320 |